Home・Lista de Ações・Humana Inc

Humana Inc

Fechado

SetorSaúde

386.84 0.59

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

380

Máximo

389.39

Indicadores-chave
By Trading Economics
Rendimento	-491M 693M
Vendas	1.2B 41B
P/E Médio do Setor	36.353 57.002
EPS	7.61
Rendimento de Dividendos	0.92
Margem de lucro	1.696
Funcionários	67,060
EBITDA	-658M 1.3B

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+10.49% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	0.92% 2.22%
Próximos Ganhos	4 de nov. de 2026
Próxima data de dividendos	30 de out. de 2026
Próxima data de ex-dividendo	25 de set. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-427M 46B
Abertura anterior	386.25
Fecho anterior	386.84

Sentimento de Notícias

By Acuity

17%

83%

43 / 340 Ranking em Healthcare

Humana Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de ago. de 2026, 19:46 UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

12 de ago. de 2026, 20:01 UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

10 de ago. de 2026, 19:16 UTC

News

Humana shares advance as JPMorgan raises price target to $393.

7 de ago. de 2026, 20:03 UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

6 de ago. de 2026, 23:02 UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

5 de ago. de 2026, 19:56 UTC

News

Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

4 de ago. de 2026, 20:04 UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

3 de ago. de 2026, 22:26 UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

31 de jul. de 2026, 19:36 UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

30 de jul. de 2026, 18:36 UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

29 de jul. de 2026, 23:06 UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

28 de jul. de 2026, 23:16 UTC

News

Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

27 de jul. de 2026, 19:16 UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

24 de jul. de 2026, 19:31 UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

22 de jul. de 2026, 19:26 UTC

Humana Inc. shares are lower today amid notable volatility and a mixed performance in global markets, with U.S. indices generally declining.

20 de jul. de 2026, 18:46 UTC

Humana Inc's shares are higher today, reflecting a slight increase since Friday's close. The stock is near the upper end of its one-month trading range.

Comparação entre Pares

Variação de preço

Humana Inc Previsão

Preço-alvo

By TipRanks

10.49% parte superior

Previsão para 12 meses

Média 429.86 USD 10.49%

Máximo 624 USD

Mínimo 280 USD

Com base em 23 analistas de Wall Street que oferecem metas de preço de 12 meses para Humana Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

23 ratings

Comprar

Manter

Vender

Com base em 23 analistas que deram avaliações de ações para Humana Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

43 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.